Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL.

PLoS Pathog. 2011 Oct;7(10):e1002337. doi: 10.1371/journal.ppat.1002337. Epub 2011 Oct 27.

2.

Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.

Blyth GA, Chan WF, Webster RG, Magor KE.

J Virol. 2015 Oct 14;90(1):103-16. doi: 10.1128/JVI.01593-15. Print 2016 Jan 1.

3.

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.

Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB.

PLoS Pathog. 2014 Apr 3;10(4):e1004048. doi: 10.1371/journal.ppat.1004048. eCollection 2014 Apr.

4.

Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Sun X, Zeng H, Kumar A, Belser JA, Maines TR, Tumpey TM.

J Virol. 2016 Nov 28;90(24):11157-11167. Print 2016 Dec 15.

5.

Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.

Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH.

J Biol Chem. 2013 Jun 14;288(24):17261-71. doi: 10.1074/jbc.M112.438515. Epub 2013 May 6.

6.

Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.

Suddala KC, Lee CC, Meraner P, Marin M, Markosyan RM, Desai TM, Cohen FS, Brass AL, Melikyan GB.

PLoS Pathog. 2019 Jan 14;15(1):e1007532. doi: 10.1371/journal.ppat.1007532. eCollection 2019 Jan.

7.

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.

John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, Savidis G, Smith SE, Elia AE, Everitt AR, Vora M, Pertel T, Elledge SJ, Kellam P, Brass AL.

J Virol. 2013 Jul;87(14):7837-52. doi: 10.1128/JVI.00481-13. Epub 2013 May 8.

8.

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.

Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, Jung JU.

Cell Host Microbe. 2013 Apr 17;13(4):452-64. doi: 10.1016/j.chom.2013.03.006. Erratum in: Cell Host Microbe. 2013 Nov 13;14(5):600-1.

9.

The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.

Li C, Du S, Tian M, Wang Y, Bai J, Tan P, Liu W, Yin R, Wang M, Jiang Y, Li Y, Zhu N, Zhu Y, Li T, Wu S, Jin N, He F.

Front Immunol. 2018 Feb 16;9:228. doi: 10.3389/fimmu.2018.00228. eCollection 2018.

10.

IFITM3 restricts the morbidity and mortality associated with influenza.

Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB; GenISIS Investigators; MOSAIC Investigators, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P.

Nature. 2012 Mar 25;484(7395):519-23. doi: 10.1038/nature10921.

11.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

12.

S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.

Yount JS, Karssemeijer RA, Hang HC.

J Biol Chem. 2012 Jun 1;287(23):19631-41. doi: 10.1074/jbc.M112.362095. Epub 2012 Apr 17.

13.

Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus.

K├╝hnl A, Musiol A, Heitzig N, Johnson DE, Ehrhardt C, Grewal T, Gerke V, Ludwig S, Rescher U.

MBio. 2018 Jul 24;9(4). pii: e01345-18. doi: 10.1128/mBio.01345-18.

14.

IFITM3 polymorphism rs12252-C restricts influenza A viruses.

Williams DE, Wu WL, Grotefend CR, Radic V, Chung C, Chung YH, Farzan M, Huang IC.

PLoS One. 2014 Oct 14;9(10):e110096. doi: 10.1371/journal.pone.0110096. eCollection 2014.

15.

Alphavirus Restriction by IFITM Proteins.

Weston S, Czieso S, White IJ, Smith SE, Wash RS, Diaz-Soria C, Kellam P, Marsh M.

Traffic. 2016 Sep;17(9):997-1013. doi: 10.1111/tra.12416. Epub 2016 Jun 24.

16.

Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.

Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, Kellam P, Fife M.

J Virol. 2013 Dec;87(23):12957-66. doi: 10.1128/JVI.01443-13. Epub 2013 Sep 25.

17.

Antiviral Role of IFITM Proteins in Classical Swine Fever Virus Infection.

Li C, Zheng H, Wang Y, Dong W, Liu Y, Zhang L, Zhang Y.

Viruses. 2019 Jan 30;11(2). pii: E126. doi: 10.3390/v11020126.

18.

mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.

Shi G, Ozog S, Torbett BE, Compton AA.

Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10069-E10078. doi: 10.1073/pnas.1811892115. Epub 2018 Oct 9.

19.

ZMPSTE24 Is Downstream Effector of Interferon-Induced Transmembrane Antiviral Activity.

Li S, Fu B, Wang L, Dorf ME.

DNA Cell Biol. 2017 Jul;36(7):513-517. doi: 10.1089/dna.2017.3791. Epub 2017 Jun 8.

20.

Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses.

Benfield CT, Smith SE, Wright E, Wash RS, Ferrara F, Temperton NJ, Kellam P.

J Gen Virol. 2015 May;96(Pt 5):991-1005. doi: 10.1099/vir.0.000058. Epub 2015 Jan 22.

Supplemental Content

Support Center